SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 25th, 2023 • Aligos Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 25th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 23, 2023 (the “Effective Date”), among Aligos Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).